Barra F, Ferrero S. Adhesion proteins: Suitable therapeutic targets or biomarkers of therapy response for endometriosis? Acta Obstet Gynecol Scand 2019;98:810-811. https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/aogs.13533
Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas
Tantari M, Barra F, Di Domenico S, Ferraioli D, Vellone VG, De Cian F, Ferrero S. Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas. Expert Opin Pharmacother 2019;20:713-723. https://www.tandfonline.com/doi/abs/10.1080/14656566.2019.1571042?journalCode=ieop20
Pathophysiology of pain in patients with peritoneal endometriosis
Ferrero S, Vellone VG, Barra F. Pathophysiology of pain in patients with peritoneal endometriosis. Ann Transl Med. 2019 Mar;7(Suppl 1):S8. doi: 10.21037/atm.2019.01.36. http://atm.amegroups.com/article/view/23517/23187
Inhibitory kappa B alpha expression in endometriosis
Barra F, Desideri LF, Scala C, Ferrero S. Inhibitory kappa B alpha expression in endometriosis. Turk J Obstet Gynecol 2018;15:277-278. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334246/
Proteomics in the Diagnosis of Endometriosis: Opportunities and Challenges
Ferrero S. Proteomics in the Diagnosis of Endometriosis: Opportunities and Challenges. Proteomics Clin Appl 2019;13:e1800183. https://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201800183
Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer
Barra F, Evangelisti G, Ferro Desideri L, Di Domenico S, Ferraioli D, Vellone VG, De Cian F, Ferrero S. Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer. Expert Opin Investig Drugs 2019;28:131-142. https://www.tandfonline.com/doi/abs/10.1080/13543784.2018.1558202?journalCode=ieid20
Hormonal contraception in women with endometriosis: a systematic review
Grandi G, Barra F, Ferrero S, Sileo FG, Bertucci E, Napolitano A, Facchinetti F. Hormonal contraception in women with endometriosis: a systematic review. Eur J Contracept Reprod Health Care 2019;24:61-70. https://www.tandfonline.com/doi/abs/10.1080/13625187.2018.1550576?journalCode=iejc20
New prophylactics human papilloma virus (HPV) vaccines against cervical cancer
Barra F, Leone Roberti Maggiore U, Bogani G, Ditto A, Signorelli M, Martinelli F, Chiappa V, Lorusso D, Raspagliesi F, Ferrero S. New prophylactics human papilloma virus (HPV) vaccines against cervical cancer. J Obstet Gynaecol 2019;39:1-10. https://www.tandfonline.com/doi/abs/10.1080/01443615.2018.1493441?journalCode=ijog20
To the Editor. Menopause.
Ferro Desideri L, Barra F, Scala C, Ferrero S. To the Editor. Menopause. 2018;25:1165. https://journals.lww.com/menopausejournal/fulltext/10.1097/GME.0000000000001151
Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis
Barra F, Desideri LF, Scala C, Ferrero S. Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis. Avicenna J Med Biotechnol 2018;10:277-278. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252036/